EBS - Emergent Biosolutions GAAP EPS of -$3.65 revenue of $165M
2023-05-09 16:21:12 ET
- Emergent Biosolutions press release ( NYSE: EBS ): Q1 GAAP EPS of -$3.65.
- Revenue of $165M (-46.3% Y/Y).
- Shares -0.41% .
- Net loss of $183M and adjusted EBITDA of negative $101M
- Guidance FY: Total Revenues $1,100M - $1,200M; Net Loss $(185M) - $(135M)
For further details see:
Emergent Biosolutions GAAP EPS of -$3.65, revenue of $165M